antiviral drug development

CAMBRIDGE, UK, Sept. 1, 2026 AstraZeneca and Daiichi Sankyo announced that the European Commission has approved Enhertu (trastuzumab deruxtecan)...

SAN FRANCISCO, California, Sept. 2, 2026 Enliven Therapeutics announced plans to present new clinical and preclinical data from its...

BRUSSELS, Belgium and ATLANTA, Georgia, Aug. 31, 2026 UCB has reached an agreement with the U.S. government aimed at...

BOSTON, Aug. 31, 2026 TransCode Therapeutics announced the publication of new peer-reviewed research reporting a survival benefit for TTX-MC138...

Raleigh, North Carolina, August 31, 2026 RedHill Biopharma Ltd. announced an update on the emergency development of opaganib as...

Newtown, Pennsylvania | February 19, 2026 — Traws Pharma announced completion of its clinical analysis evaluating ratutrelvir, an investigational...

Shelton, Connecticut — February 10, 2026: NanoViricides, Inc., a clinical-stage antiviral nanomedicine company, announced the filing of an Orphan...